Literature DB >> 11798241

Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus.

M Bray1, S Hatfill, L Hensley, J W Huggins.   

Abstract

Ebola Zaire virus from the 1976 outbreak (EBO-Z) was recently adapted to the stage of lethal virulence in BALB/c mice through serial passage. In the present study, various parameters were examined in groups of mice and guinea-pigs and in three rhesus monkeys after infection with mouse-adapted EBO-Z. The virus caused fatal disease not only in mice but also in guinea-pigs, in which the course of illness resembled that produced by guinea-pig-adapted EBO-Z. Mice, guinea-pigs and monkeys showed similar haematological and biochemical disturbances, but coagulopathy was less striking in mice than in the other two species. The virus caused severe illness in all three monkeys, one of which died. In the lethally infected monkey the degree of viraemia and the haematological, serum biochemical and coagulation changes were greater than in the other two animals, an observation that may prove to be of value in predicting fatal outcome. All three monkeys developed disseminated intravascular coagulation. The two survivors were completely resistant to challenge one year later with non-adapted EBO-Z. In general, the clinical and pathological changes produced in the three species resembled those previously described in guinea-pigs and non-human primates infected with non-mouse-adapted EBO-Z. It was noteworthy, however, that mouse-adaptation appeared to have resulted in a degree of attenuation for monkeys. Copyright Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11798241     DOI: 10.1053/jcpa.2001.0503

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  54 in total

1.  Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.

Authors:  Loreen L Lofts; Jay B Wells; Sina Bavari; Kelly L Warfield
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.

Authors:  Catherine L Hunt; Andrey A Kolokoltsov; Robert A Davey; Wendy Maury
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

Review 3.  Considerations for Infectious Disease Research Studies Using Animals.

Authors:  Lesley A Colby; Lauriane E Quenee; Lois A Zitzow
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

4.  Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.

Authors:  Thomas W Geisbert; James E Strong; Heinz Feldmann
Journal:  J Infect Dis       Date:  2015-06-10       Impact factor: 5.226

5.  Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.

Authors:  Cristian Cilloniz; Hideki Ebihara; Chester Ni; Gabriele Neumann; Marcus J Korth; Sara M Kelly; Yoshihiro Kawaoka; Heinz Feldmann; Michael G Katze
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

6.  Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

Authors:  Andrea Rivera; Ilhem Messaoudi
Journal:  ACS Infect Dis       Date:  2015-03-30       Impact factor: 5.084

7.  Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Authors:  Nadia Wauquier; Pierre Becquart; Cindy Padilla; Sylvain Baize; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

8.  Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus).

Authors:  Sophie J Smither; Michelle Nelson; Lin Eastaugh; Thomas R Laws; Christopher Taylor; Simon A Smith; Francisco J Salguero; Mark S Lever
Journal:  Int J Exp Pathol       Date:  2013-02-27       Impact factor: 1.925

Review 9.  Post-exposure treatments for Ebola and Marburg virus infections.

Authors:  Robert W Cross; Chad E Mire; Heinz Feldmann; Thomas W Geisbert
Journal:  Nat Rev Drug Discov       Date:  2018-01-29       Impact factor: 84.694

10.  Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.

Authors:  Amy L Hartman; Ling Ling; Stuart T Nichol; Martin L Hibberd
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.